Business Segment Information

12 Months Ended

Oct. 31, 2023

Segment Reporting [Abstract]

Business Segment Information

Note 12. Business Segment Information

The Company discloses information about its operating segments, which were established based on the way that management organizes segments within the Company for making operating decisions and assessing financial performance. The Company's two operating segments are described below.

•CooperVision. Competes in the worldwide contact lens market by developing, manufacturing and marketing a broad range of products for contact lens wearers, featuring advanced materials and optics.

•CooperSurgical. Competes in the general health care market with a focus on advancing the health of women, babies and families through a diversified portfolio of products and services focusing on women's health and fertility.

The Company uses operating income, as presented in our financial reports, as the primary measure of segment profitability. The Company does not allocate costs from corporate functions to segment operating income. The Company uses the same accounting policies to generate segment results as it does for consolidated results.

No customers accounted for 10% or more of our consolidated net revenue in fiscal 2023, 2022 and 2021.

Total identifiable assets are those used in continuing operations except cash and cash equivalents, which the Company includes as corporate assets.

The following table presents a summary of our business segment net sales:

(In millions)	2023		2022		2021
CooperVision net sales by category:
Toric lens	$	828.7	$	737.4	$	697.5
Multifocal lens	305.7		264.4		238.6
Single-use sphere lens	705.4		661.6		616.3
Non single-use sphere, other	583.9		579.9		599.6
Total CooperVision net sales	2,423.7		2,243.3		2,152.0
CooperSurgical net sales by category:
Office and surgical	689.5		633.6		451.3
Fertility	480.0		431.5		319.2
Total CooperSurgical net sales	1,169.5		1,065.1		770.5
Total net sales	$	3,593.2	$	3,308.4	$	2,922.5

Information by business segment for each of the years in the three-year period ended October 31, 2023 follows:

(In millions)	CooperVision		CooperSurgical		Corporate		Consolidated
2023
Net sales	$	2,423.7	$	1,169.5	$	—	$	3,593.2
Operating income (loss)	$	587.7	$	16.1	$	(70.7)	$	533.1
Interest expense							105.3
Other expense, net							14.9
Income before income taxes							$	412.9
Identifiable assets	$	7,044.0	$	4,351.8	$	263.1	$	11,658.9
Depreciation expense	$	156.9	$	24.6	$	—	$	181.5
Amortization expense	$	32.9	$	153.3	$	—	$	186.2
Capital expenditures	$	364.4	$	28.1	$	—	$	392.5
2022
Net sales	$	2,243.3	$	1,065.1	$	—	$	3,308.4
Operating income (loss)	$	494.3	$	67.1	$	(53.8)	$	507.6
Interest expense							57.3
Other (income), net							(25.0)
Income before income taxes							$	475.3
Identifiable assets	$	6,778.9	$	4,407.8	$	305.6	$	11,492.3
Depreciation expense	$	144.5	$	22.1	$	—	$	166.6
Amortization expense	$	32.3	$	147.2	$	—	$	179.5
Capital expenditures	$	223.0	$	19.0	$	—	$	242.0
2021
Net sales	$	2,152.0	$	770.5	$	—	$	2,922.5
Operating income (loss)	$	481.3	$	71.8	$	(47.3)	$	505.8
Interest expense							23.1
Other expense, net							(8.8)
Income before income taxes							$	491.5
Identifiable assets	$	6,965.9	$	2,395.6	$	244.7	$	9,606.2
Depreciation expense	$	148.3	$	14.9	$	—	$	163.2
Amortization expense	$	35.7	$	110.4	$	—	$	146.1
Capital expenditures	$	190.0	$	24.4	$	—	$	214.4

Information by geographical area by country of domicile for each of the years in the three-year period ended October 31, 2023 follows:

(In millions)	United States		Europe		Rest of World, Other Eliminations & Corporate		Consolidated
2023
Net sales to unaffiliated customers	$	1,812.2	$	1,041.2	$	739.8	$	3,593.2
Sales between geographic areas	563.1		1,016.7		(1,579.8)		—
Net sales	$	2,375.3	$	2,057.9	$	(840.0)	$	3,593.2
Operating income	$	—	$	516.2	$	16.9	$	533.1
Long-lived assets	$	1,027.6	$	325.9	$	279.1	$	1,632.6
2022
Net sales to unaffiliated customers	$	1,638.5	$	987.2	$	682.7	$	3,308.4
Sales between geographic areas	514.4		897.3		(1,411.7)		—
Net sales	$	2,152.9	$	1,884.5	$	(729.0)	$	3,308.4
Operating (loss) income	$	71.8	$	403.8	$	32.0	$	507.6
Long-lived assets	$	856.1	$	310.8	$	266.0	$	1,432.9
2021
Net sales to unaffiliated customers	$	1,339.2	$	957.9	$	625.4	$	2,922.5
Sales between geographic areas	494.9		815.1		(1,310.0)		—
Net sales	$	1,834.1	$	1,773.0	$	(684.6)	$	2,922.5
Operating (loss) income	$	(26.8)	$	416.2	$	116.4	$	505.8
Long-lived assets	$	737.5	$	377.2	$	232.9	$	1,347.6